What Eli Lilly, Novo Nordisk Earnings Reveal About the Future of GLP-1 Sales
Novo Nordisk A/S (NVO): Navellier & Associates Is Bullish on This Stock Right Now
23andMe Shuts Down Therapeutics Discovery Unit, Launching GLP-1 Telehealth Offering
Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug
Moovin Stonks | Friday Market Calm Before Storm After Turbulent Week
What Eli Lilly, Novo Nordisk Earnings Show About GLP-1 Sales
European Equities Traded in the US as American Depositary Receipts Rise Friday
U.S. stock market anomaly | Weight loss concept stocks rise, Eli Lilly and Co (LLY.US) rose more than 6.8%.
As of press time, the stock rose more than 6.8%, reporting $903.
Express News | Novo Nordisk Shares Are Trading Higher. The Stock May Be up After Eli Lily on Thursday Raised Its Guidance, Primarily Driven by the Performance of Mounjaro and Zepbound
Eli Lilly Is Gaining on Novo Nordisk in the Obesity Race -- Heard on the Street -- WSJ
Why GLP-1s Can Be a 'Half a Trillion Dollar Market': Tema ETF CEO
Eli Lilly & Co (LLY) Buy Rating Affirmed on Strong HFpEF Data and Competitive Edge Over Novo Nordisk (NVO)
Novo Nordisk Share Pullback Represents Great Opportunity
"Weight loss drug champions" showdown: Eli Lilly and Co's Q2 net profit increased almost 70%, catching up with Novo Nordisk?
Crazy weight-loss pills.
S&P rises over 2%, the best in nearly two years, with chip stocks up about 7%, Nasdaq and Chinese stocks up 2.8%, and US Treasury yields and the yen falling for three consecutive days.
The latest employment data alleviates concerns over the US economy, and US stocks rose more than 1.7%. Nvidia's stock rose more than 6%, and Tesla, Alibaba, PDD Holdings, and Tencent ADR rose more than 3%. Bullish on weight loss drug reports, Eli Lilly and Co's stock rose more than 13%, and Novo-Nordisk A/S's US stock rose nearly 8%. The 10-year US Treasury yield rose above 4%, and short-term bond yields rose by 10 basis points. Oil prices rose for the third consecutive day, gold halted its five-day decline, and digital currency had a big increase.
The GLP-1 Makers to Add to Your Portfolio: Tema ETFs CEO
Novo Nordisk Is Maintained at Outperform by BMO Capital
Novo Nordisk Analyst Ratings
Eli Lilly Shows We Haven't Hit Peak Obesity Yet -- WSJ
European Equities Traded in the US as American Depositary Receipts Climb Higher in Thursday Trading